How Barley's Beta-Glucan Works
Barley typically contains 4–9 g of beta-glucan per 100 g of dry grain — often matching or exceeding oats. Beta-glucan is a soluble fiber that dissolves in water and forms a viscous, gel-like substance as it moves through the small intestine.
This gel works through several mechanisms simultaneously:
Lowers cholesterol through bile acid trapping. Bile acids — synthesized by the liver from cholesterol — normally get reabsorbed in the small intestine and recycled. Beta-glucan gel binds bile acids and carries them out in the stool instead. The liver responds by pulling more LDL cholesterol from the blood to make replacement bile acids, driving a net reduction in circulating LDL. Meta-analyses consistently show this reduces LDL cholesterol by around 7% at doses of 3–7 g per day [1][2].
Slows glucose absorption. The same viscous gel slows the rate at which carbohydrates are digested and glucose enters the bloodstream, producing a lower, slower blood sugar response after meals. Whole grain barley has one of the lowest glycemic indexes among common grains — around 25–30 — compared to 55–70 for most wheat products [3].
Acts as prebiotic fiber. In the large intestine, beta-glucan that escapes digestion is fermented by bacteria into short-chain fatty acids (SCFAs), primarily butyrate, propionate, and acetate. Butyrate is the main fuel for colonocytes — the cells lining the colon — and has anti-inflammatory properties. Barley consumption consistently increases beneficial bacterial populations including Bifidobacterium and Lactobacillus [5].
Beyond Beta-Glucan: Barley's Other Bioactives
Barley contains additional functional compounds that set it apart from isolated beta-glucan supplements:
Tocols are the vitamin E family compounds (tocopherols and tocotrienols) concentrated in the bran. Barley is one of the richest grain sources of tocotrienols — forms of vitamin E with notably stronger antioxidant and anti-inflammatory activity than the more common tocopherols found in most vegetable oils [4].
Polyphenols including ferulic acid, catechins, procyanidins, and the flavone lutonarin are most concentrated in the outer bran layers. They are more abundant in hulled barley than in pearl barley, where the bran has been removed [4].
Phytosterols in barley (primarily beta-sitosterol and campesterol) compete with dietary cholesterol for intestinal absorption, adding a secondary cholesterol-lowering mechanism that compounds the beta-glucan effect.
Resistant starch — the fraction that escapes digestion and reaches the colon — adds another layer to barley's prebiotic profile, distinct from beta-glucan.
Hulled vs. Pearl Barley
The form of barley you choose makes a meaningful difference in nutritional value:
- Hulled barley (pot barley): Only the tough outer husk is removed; the fiber-rich bran remains intact. Highest content of beta-glucan, polyphenols, and tocols. Chewy texture, requires longer cooking (45–60 minutes).
- Pearl barley: The bran has been polished off, leaving the starchy interior. More convenient and faster to cook, and still contains useful beta-glucan (distributed throughout the endosperm, not only in the bran), but lower in polyphenols, tocols, and insoluble fiber.
- Barley flakes and flour: Processed forms that retain varying amounts of beta-glucan depending on milling method. Stone-milled barley flour retains more than highly refined versions.
For maximum benefit, hulled barley is the better choice. Pearl barley still provides a meaningful beta-glucan dose and has a milder flavor that many people find more approachable for everyday cooking.
Practical Use
The FDA health claim is based on 3 g of barley beta-glucan per day:
- 150 g cooked hulled barley (roughly half a cup dry) provides approximately 3–4 g of beta-glucan
- Pearl barley provides approximately 2–3 g per equivalent serving
A single serving — added to soups, stews, grain bowls, or as a rice substitute — is enough to hit the effective threshold. Most studies showing cholesterol-lowering effects used 4–8 week intervention periods, so consistency over weeks matters more than occasional large servings.
See our Oats page for comparison with another beta-glucan-rich grain, and the Beta-Glucans page for a broader overview of how this fiber class works.
Evidence Review
Cholesterol Reduction — Meta-Analyses
Ho et al. (2016) conducted a systematic review and meta-analysis of RCTs specifically examining barley beta-glucan's effect on cardiovascular lipid markers — the most comprehensive barley-focused analysis to date [1]. Pooled findings:
- LDL-C: approximately −7% (mean −0.21 mmol/L) at median intake of 6.5 g/day
- Non-HDL-C: approximately −7% (mean −0.22 mmol/L) at median intake of 6.9 g/day
- ApoB: significant reduction consistent across trials
- No significant effect on HDL-C or triglycerides
Dose-response was evident: higher beta-glucan doses and higher molecular weight preparations produced larger effects. The authors concluded that barley beta-glucan was comparably effective to oat beta-glucan for LDL reduction — supporting the shared FDA health claim for both grains.
AbuMweis et al. (2010) analyzed 11 RCTs examining whole barley grain or isolated barley beta-glucan versus control diets [2]. Pooled results from dose ranges of 3–10 g/day:
- Total cholesterol: −0.30 mmol/L (statistically significant)
- LDL cholesterol: −0.27 mmol/L (statistically significant)
The effect was consistent across studies using both whole grain barley and concentrated beta-glucan preparations, confirming that beta-glucan is the primary active component — while noting that whole grain barley likely provides additive benefits from polyphenols and phytosterols that supplements omit.
Both meta-analyses support the same mechanistic explanation: beta-glucan gel disrupts enterohepatic bile acid recirculation, forcing the liver to upregulate LDL receptor expression and clear more LDL from the blood.
Glycemic Response
Tosh and Bordenave (2020) reviewed the evidence for whole grain barley effects on glycemic response [3]. Key findings:
- Multiple RCTs show whole grain barley has a substantially lower glycemic index than wheat bread or white rice
- The glycemic benefit depends on the viscosity of beta-glucan in the preparation — processing conditions that reduce beta-glucan molecular weight (high heat, prolonged storage, fine milling) attenuate the effect
- Postprandial glucose reductions of 20–30% compared to refined grain controls have been reported in several independent trials
- For longer-term HbA1c outcomes in at-risk populations, evidence is emerging but less extensive than for acute glycemic response
The molecular weight point is practically important: freshly cooked hulled barley, where beta-glucan remains structurally intact, produces a more pronounced glycemic effect than pre-cooked or highly milled barley products.
Comprehensive Nutraceutical Profile
Zhang et al. (2023) reviewed barley's full functional compound composition [4]. Notable findings:
- Beta-glucan content by variety: 4–11 g/100 g in hull-less barley varieties; 3–7 g/100 g in pearl barley
- Polyphenol content: dominated by bound ferulic acid in the cell walls; flavonoids including lutonarin (glucosyl-orientin) concentrated in bran layers
- Tocol content: barley is one of the richest grain sources of tocotrienols; tocotrienols have been shown in separate research to inhibit HMG-CoA reductase (the same enzyme targeted by statin drugs) through a distinct mechanism
- Phytosterol content: approximately 70–100 mg/100 g of whole grain — sufficient to contribute measurably to cholesterol reduction
- Bioprocessing note: germination, malting, and fermentation can increase polyphenol bioavailability and modify beta-glucan structure; malt barley (used in brewing) has distinct properties from food-grade barley
Immune System and Gut Microbiota — Systematic Review
Cortijo-Alfonso et al. (2024) systematically reviewed 23 RCTs (1,091 participants) examining oat and barley effects on immune function, inflammation, and gut microbiota [5]. For barley-containing interventions:
- Inflammation: 5 of 9 studies measuring inflammatory biomarkers found significant reductions. Effects were confined to long-term interventions (>14 days) and metabolically at-risk populations (obesity, dyslipidemia, metabolic syndrome). No significant anti-inflammatory effect was found in healthy subjects over short periods.
- Gut microbiota: 13 studies reported compositional changes; predominant findings included increases in Bifidobacterium and Lactobacillus species, with some studies also reporting reductions in potentially harmful bacteria
- Short-chain fatty acids: increases in propionate and acetate were reported in several studies alongside microbiota changes
The finding that anti-inflammatory effects appear primarily in metabolically at-risk populations — rather than in healthy controls — is consistent with a well-recognized pattern in nutritional research: dietary interventions tend to produce larger absolute effects where baseline dysfunction is present. For gut microbiota, improvements were seen across a wider range of participants.
Evidence Quality Summary
| Outcome |
Evidence Level |
Notes |
| LDL cholesterol reduction |
Strong (multiple RCTs, meta-analyses) |
FDA and EFSA health claim; effect size ~7% at 3–7 g/day |
| Non-HDL and apoB reduction |
Moderate-Strong |
Clinically relevant cardiovascular endpoints |
| Glycemic and blood sugar control |
Moderate |
Processing-dependent; intact grain consistently outperforms refined forms |
| Gut microbiota improvement |
Moderate |
Consistent direction across RCTs; effect in healthy and at-risk populations |
| Anti-inflammatory effects |
Moderate (at-risk populations) |
Less consistent in healthy subjects; longer duration needed |
Barley is among the most evidence-backed whole grains for cardiovascular and metabolic risk reduction. Its beta-glucan content — frequently comparable to or higher than oats — gives it a clinically recognized cholesterol-lowering effect, while its polyphenol, tocotrienol, and phytosterol profile provides antioxidant and anti-inflammatory properties that isolated beta-glucan supplements do not replicate.